News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News US Preventive Services Task Force: Insufficient Evidence to Recommend ECG Screening for A-fib Detection L.A. McKeown August 07, 2018
News Daily News Silent A-fib That Progresses Signals a Higher Heart Failure Risk Todd Neale June 06, 2018
News Conference News HRS 2018 HRS: Here’s How to Talk About Cybersecurity Concerns and Implantable Devices Todd Neale May 17, 2018
News Conference News HRS 2018 NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low Todd Neale May 11, 2018
News Conference News ACC 2018 Smartwatch Device Accurately Detects A-fib Before Cardioversion Todd Neale March 02, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2018 Shelley Wood March 01, 2018
News Daily News FDA Warns Certain Zoll LifeVests Might Fail to Deliver Shocks Michael O'Riordan January 17, 2018
News Conference News TCT 2017 Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used Todd Neale November 02, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Opinion Editor's Corner ESC 2017 My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back Shelley Wood September 08, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Daily News One in Four ICD Patients Need Reintervention Within 5 Years Ashley Lyles August 04, 2017
News Daily News Implanted Devices May Help Determine Time and Cause of Death When Autopsy Falls Short Yael L. Maxwell June 26, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017